These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20100562)

  • 1. Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation.
    Ribas GS; Manfredini V; de Mari JF; Wayhs CY; Vanzin CS; Biancini GB; Sitta A; Deon M; Wajner M; Vargas CR
    Int J Dev Neurosci; 2010 Apr; 28(2):127-32. PubMed ID: 20100562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.
    Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of butyrylcholinesterase activity in plasma from patients with disorders of propionate metabolism is prevented by treatment with L-carnitine and protein restriction.
    Ribas GS; Scherer EB; Ferreira AG; Schmitz F; Wyse AT; Rodrigues D; Nascimento S; Garcia SC; Wajner M; Vargas CR
    Clin Biochem; 2012 Jan; 45(1-2):77-81. PubMed ID: 22079397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.
    Böhles H; Lehnert W
    Eur J Pediatr; 1984 Nov; 143(1):61-3. PubMed ID: 6510434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine reduces fasting ketogenesis in patients with disorders of propionate metabolism.
    Wolff JA; Carroll JE; Le Phuc Thuy ; Prodanos C; Haas R; Nyhan WL
    Lancet; 1986 Feb; 1(8476):289-91. PubMed ID: 2868163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention by L-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro.
    Ribas GS; Manfredini V; de Marco MG; Vieira RB; Wayhs CY; Vanzin CS; Biancini GB; Wajner M; Vargas CR
    Mutat Res; 2010 Sep; 702(1):123-8. PubMed ID: 20659584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism.
    Burns SP; Iles RA; Saudubray JM; Chalmers RA
    Eur J Pediatr; 1996 Jan; 155(1):31-5. PubMed ID: 8750807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: Relevance for metabolic acidemias.
    Colín-González AL; Paz-Loyola AL; Serratos I; Seminotti B; Ribeiro CA; Leipnitz G; Souza DO; Wajner M; Santamaría A
    Neuroscience; 2015 Nov; 308():64-74. PubMed ID: 26343296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
    Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
    J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation.
    Duran M; Ketting D; Beckeringh TE; Leupold D; Wadman SK
    J Inherit Metab Dis; 1986; 9(2):202-7. PubMed ID: 3091925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
    Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency.
    Di Donato S; Rimoldi M; Garavaglia B; Uziel G
    Clin Chim Acta; 1984 May; 139(1):13-21. PubMed ID: 6723070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis.
    Malek Mahdavi A; Mahdavi R; Kolahi S; Zemestani M; Vatankhah AM
    Nutr Res; 2015 Aug; 35(8):707-15. PubMed ID: 26149189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention by L-carnitine of DNA damage induced by 3-hydroxy-3-methylglutaric and 3-methylglutaric acids and experimental evidence of lipid and DNA damage in patients with 3-hydroxy-3-methylglutaric aciduria.
    Delgado CA; Balbueno Guerreiro GB; Diaz Jacques CE; de Moura Coelho D; Sitta A; Manfredini V; Wajner M; Vargas CR
    Arch Biochem Biophys; 2019 Jun; 668():16-22. PubMed ID: 31047871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria.
    Dos Santos Mello M; Ribas GS; Wayhs CA; Hammerschmidt T; Guerreiro GB; Favenzani JL; Sitta Â; de Moura Coelho D; Wajner M; Vargas CR
    Mol Cell Biochem; 2015 Apr; 402(1-2):149-55. PubMed ID: 25557019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.